Showing 2,683 results

Filters Content type: News, Editors' picks, About HIV Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Access to healthcare

How India's Patent Office Destroyed Gilead's Global Game Plan

Editor's pick
Bloomberg Businessweek
19 January 2015
Hepatitis C treatment

The Cynical Connectedness of Gilead's Hepatitis C Pricing and Anti-Diversion Policies

Editor's pick
The Body Pro
19 January 2015
Access to healthcare

Hepatitis C drug delayed by NHS due to high cost

Editor's pick
The Guardian
16 January 2015
Hepatitis C treatment

European Commission Grants Marketing Authorizations for AbbVie's VIEKIRAX® (ombitasvir/paritaprevir/ritonavir tablets) + EXVIERA® (dasabuvir tablets) for the Treatment of Chronic Hepatitis C

Editor's pick
AbbVie press release
16 January 2015
Hepatitis C symptoms & diagnosis

NICE plans to support device for diagnosing liver damage without surgery

Editor's pick
NICE
15 January 2015
Hepatitis C treatment

How Much Could AbbVie Inc. Make Selling Its Hepatitis C Drug This Year?

Editor's pick
The Motley Fool
15 January 2015
Hepatitis C treatment

India rejects Gilead's Hepatitis C drug patent request

Editor's pick
Reuters
14 January 2015
Hepatitis C symptoms & diagnosis

Doctors Question Wider Hepatitis C Screening Despite Cures

Editor's pick
Bloomberg
14 January 2015
Hepatitis C treatment

US: Prime Therapeutics breaks from competition, strikes deals to prefer both Harvoni, Viekira hepatitis C drugs

Editor's pick
Prime Therapeutics press release
13 January 2015
New & experimental hepatitis C treatment

Merck speeds up drug-submission plans for hep C, lung cancer

Editor's pick
Reuters
13 January 2015
People who inject drugs

HCV prevention campaigns need to focus on reducing frequency of injecting drug use involving sharing of equipment

News
13 January 2015
Access to healthcare

Spaniards rally over hepatitis C drugs

Editor's pick
Press TV
12 January 2015
Hepatitis C treatment

Interferon-free combination therapy prevents recurrence of HCV after liver transplantation

Editor's pick
Eurekalert Inf Dis
9 January 2015
Hepatitis C treatment

VA, DoD spend more than $450M on costly hepatitis drug

Editor's pick
USA Today
9 January 2015
Hepatitis C treatment

Anthem selects Gilead as primary supplier of hepatitis C drugs

Editor's pick
Reuters
9 January 2015
Hepatitis C treatment

Gilead Strikes Hepatitis Drug Deal With CVS Health

Editor's pick
New York Times
7 January 2015
Hepatitis C treatment

Express Scripts explains exclusive AbbVie hepatitis C prescribing deal

Editor's pick
Wall Street Journal
7 January 2015
Hepatitis B

Experimental siRNA therapy lowers HBsAg levels in people with hepatitis B

News
6 January 2015
Hepatitis C treatment

Third of 2015 health basket expansion in Israel goes to hepatitis C

Editor's pick
Jerusalem Post
4 January 2015
Hepatitis C transmission & prevention

First of its kind HIV/hepatitis C (HCV) co-infection guide to help curb increasing prevalence and mortality in the UK launched

Editor's pick
56 Dean Street, via Medical News Today
29 December 2014
Hepatitis C transmission & prevention

More Evidence That HIV-Negative Gays Contract Hep C Via Sex

Editor's pick
AIDSMeds
26 December 2014
Hepatitis C treatment

Even with New AbbVie Drug, Many Hepatitis C Patients Are Being Turned Away from Treatment

Editor's pick
Hepatitis C News
23 December 2014
Hepatitis C treatment

Gilead slides after hepatitis drug setback

Editor's pick
Financial Times (free registration required)
23 December 2014
The search for a cure

New open-access journal in the rapidly developing field of virus eradication

Editor's pick
Mediscript
23 December 2014